Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
01/2007
01/11/2007WO2007004613A1 THERAPEUTIC AGENT FOR INFLAMMATORY BOWEL DISEASE AND TNF-α PRODUCTION INHIBITOR
01/11/2007WO2007004543A1 Pharmaceutical composition comprising 2-pyridone derivative as active ingredient
01/11/2007WO2007004244A1 Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
01/11/2007WO2007003957A2 Steroidal glycoside compounds as core 2 glcnac- t inhibitors
01/11/2007WO2007003386A1 Imidazopyridine derivatives as acid pump antagonists
01/11/2007WO2007003020A1 Oral formulations comprising ondansetron and a highly dosed sweeten
01/11/2007WO2006113571B1 Substituted cyclopentanones for treating inflammatory bowel disease
01/11/2007US20070010575 Intracorporeal medicaments for photodynamic treatment of disease
01/11/2007US20070010533 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
01/11/2007US20070010526 Therapeutic isoquinoline compounds
01/11/2007US20070010521 Condensed polycyclic compounds
01/11/2007US20070010517 Pharmaceutical salts of reboxetine
01/11/2007US20070010515 [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof
01/11/2007US20070010483 Glucocerebroside treatment of liver disorders
01/11/2007US20070010479 Administering pyrimidine nucleotide precursor where respiratory chain dysfunction is caused by mutation, deletion, or rearrangement of mitochondrial DNA, cytotoxic cancer chemotherapy agents, aging
01/11/2007US20070010457 Caspase inhibitors and uses thereof
01/11/2007US20070009971 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases
01/11/2007US20070009619 Neutralizing agent for cavitating toxin
01/11/2007US20070009554 Biologically active hemagglutinin from type a clostridium botulinum and methods of use
01/11/2007US20070009513 Novel method of screening
01/11/2007CA2614315A1 Activator of peroxisome proliferator activated receptor d
01/11/2007CA2614017A1 Steroidal glycoside compounds as core 2 glcnac- t inhibitors
01/11/2007CA2612893A1 Stereoisomeric pyridyl and pyridonyl compounds and methods for the treatment of gastrointestinal and central nervous system disorders
01/10/2007EP1741722A2 Polymorphisms in the human P2X7 gene
01/10/2007EP1741703A1 Pyridone derivative
01/10/2007EP1741441A1 Bone densifying agent characterized by use of cathepsin k inhibitor with pth
01/10/2007EP1741428A2 Cell adhesion inhibitors
01/10/2007EP1740553A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors
01/10/2007EP1740552A1 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors
01/10/2007EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells
01/10/2007EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands
01/10/2007EP1355916B1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
01/10/2007EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase
01/10/2007EP1313491B1 Bioactive fraction of eurycoma longifolia
01/10/2007EP1244447B1 Novel methods and compositions involving opioids and antagonists thereof
01/10/2007EP1194147B1 Arylthiazolidinedione and aryloxazolidinedione derivatives
01/10/2007EP1109803B1 Substituted imidazoles having cytokine inhibitory activity
01/10/2007EP1087946B1 Aryl alkanoylpyridazines
01/10/2007CN1894280A Glycosylation-deficient hepatocyte growth factor
01/10/2007CN1894246A Novel crystalline forms of 2,3-dimethyl-8-(2,6-dimethylbenzylamino)-n-hydroxyethyl-imidazo[1,2-a]pyridine-6-carboxamide mesylate salt
01/10/2007CN1894244A Aryl ether substituted imidazoquinolines
01/10/2007CN1894195A Ether compounds and compositions for cholesterol management and related uses
01/10/2007CN1893946A Use of a pyrazole derivative for preparing medicaments for the prevention and the treatment of dyslipidemia and illnesses associated with dyslipidemia and/or obesity
01/10/2007CN1891703A Chelerythrine compound and its preparing method
01/10/2007CN1891303A Method for preparing bile acid adsorbent of beta cyclo dextrin polymer
01/10/2007CN1891302A Drug carrier and method for preparing same
01/10/2007CN1891291A Oral liquid preparation for treating apositia in childrev, and its preparing method
01/10/2007CN1891275A Osmotic pump type controlled release preparation of liuweidihuang or its adjusted formula extract and its preparing method
01/10/2007CN1891264A Compound medicine for treating hepatitis B
01/10/2007CN1891257A Medicinal composition for treating odontia, and its preparing method
01/10/2007CN1891248A Medicinal composition for treating hepatopathy, and its preparing mehtod and use
01/10/2007CN1891241A Chinese medicine capsule and preparation
01/10/2007CN1891240A Chinese medicine composition containing multi glossy ganoderma active constituents and its preparing method
01/10/2007CN1891231A Liusheng Chinese medicine preparation and its preparing method
01/10/2007CN1891225A Adefovir dipivoxil self-emulsifiable preparation and its preparing method
01/10/2007CN1891221A Combination therapy to treat hepatitis b virus
01/10/2007CN1891210A Ranitidine bismuth citrate dispersible tablet, and its preparing method
01/10/2007CN1891209A Eplerenone crystalline form exhibiting enhanced dissolution rate
01/10/2007CN1294253C Bacterial strains, processed plant extract, composition containing thereof, preparation method and application in treatment and industry
01/10/2007CN1294136C Novel ligand for nicotinic acety/choline receptors useful in therapy
01/10/2007CN1294133C Imidazo-pyrimidine derivatives as ligands for GABA receptors
01/10/2007CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof
01/10/2007CN1294120C Pyrrolidinyl metalloprotease inhibitor and its application
01/10/2007CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors
01/10/2007CN1293910C Compound gastrodin injection and its preparation and use
01/10/2007CN1293909C Granule with ginseng and astragalus root and preparation technique thereof
01/10/2007CN1293904C Tea capable of sobering up, nourishing stomach and protecting liver
01/10/2007CN1293902C Oral deodorizing drink
01/10/2007CN1293898C Method for preparing pharmaceutical composition for treating viral hepatitis
01/10/2007CN1293889C Application of orostachys in medicine for curing gastrointestinal disease and medicament
01/10/2007CN1293886C Liver disease-treating medication possessing curative effect of hepatocinhosis and preparation method
01/10/2007CN1293884C Application of 6-methocy bideoxy bideoxy guanosine in preparation of medicine for resisting hepatitis B
01/10/2007CN1293879C Freeze-dried powder injection of pantoprazole sodium and its preparation
01/10/2007CN1293873C Andrographis herb preparation
01/09/2007US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors
01/09/2007US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives
01/09/2007US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same
01/09/2007US7160883 Pyrrolo-triazine aniline compounds useful as kinase inhibitors
01/09/2007US7160874 Phenylalanine derivatives
01/09/2007US7160872 Methods to treat conditions mediated by chemokine receptors
01/09/2007US7160558 Coating and binding agent for pharmaceutical formulations with improved storage stability
01/09/2007US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same
01/09/2007CA2467490C Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
01/09/2007CA2407538C Novel bicyclic compounds
01/09/2007CA2389325C 1-amino-alkylcyclohexane nmda receptor antagonists
01/09/2007CA2372646C Method for manufacturing rumen bypass feed supplement
01/09/2007CA2240721C Implantable acrylamide copolymer hydrogel for therapeutic uses
01/09/2007CA2186844C Use of serotonin antagonists (5ht3) for treating fibromyalgia
01/09/2007CA2077637C Compositions comprising a tramadol material and any of codeine, oxycodone or hydrocodone and their use
01/04/2007WO2007001671A1 Use of 3- or 7-thia- or 3 , 7-ditηiapr0sten0ic acid derivatives for the treatment of inflammatory bowel disease
01/04/2007WO2007001225A1 Thiophene-2-carboxamide derivatives as alpha 7 nicotinic receptor modulators.
01/04/2007WO2007001006A1 Agent for ameliorating heavy metal-induced disorders, and medicinal composition, food and cosmetic containing the same
01/04/2007WO2007000924A1 Pharmaceutical composition comprising substance capable of inhibiting or promoting progranulin activity and screening method for substance capable of inhibiting or promoting progranulin activity
01/04/2007WO2007000648A1 Pharmaceutical formulations containing colostrum and calcium folinate for te treatment of disorders of the oral cavity
01/04/2007WO2007000046A1 Methods for diagnosing functional bowel disease
01/04/2007WO2006108127A3 Crystalline form of a quinolinone-carboxamide compound
01/04/2007WO2006059106A3 Bispecific domain antibodies targeting serum albumin and glp-1 or pyy
01/04/2007US20070004807 Methods using phenethanolamine derivatives for treatment of respiratory diseases
01/04/2007US20070004800 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents
01/04/2007US20070004791 (1 alpha ,5 alpha ,6 alpha )-N-[3-benzyl-3-azabicyclo[3.1.0]hexyl-6-(aminomethyl)-yl]-2-hydroxy-2,2-diphenyl acetamide; high affinity towards Muscarinic 3 receptors; avoiding adverse side effects; for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems